Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Int J Cardiol ; 265: 40-46, 2018 Aug 15.
Article in English | MEDLINE | ID: mdl-29885699

ABSTRACT

BACKGROUND: N-terminal pro-hormone B-type natriuretic peptide (NT-proBNP) levels correlate with higher peri-procedural mortality after transcatheter aortic valve replacement (TAVR). The long-term prognostic value of NT-proBNP within the first days after TAVR, however, remains unclear. This study examined early changes in NT-proBNP prior to and within 6 days after TAVR, the diagnostic value of this biomarker regarding aortic regurgitation (AR), and its prognostic value regarding one-year mortality. METHODS AND RESULTS: NT-proBNP concentrations were measured in 504 consecutive patients undergoing transapical (TA) or transfemoral (TF) TAVR before and directly after TAVR as well as 4 h and 1, 2, 3, and 6 days after TAVR. The follow-up period was 1 year. NT-proBNP was elevated in all patients at baseline (median 2141 ng/L [IQR 1021-5319 ng/L]). NT-proBNP changes in the first 6 days after TAVR showed significant differences depending on the approach, with a greater and more prolonged rise evident in TA-TAVR patients. NT-proBNP was an independent predictor of mortality in TA patients with AR, with an AUC of 0.794 (95% CI 0.663-0.925; P = 0.003) when measured on day 3 after TAVR. For TF patients with AR and reduced left ventricular systolic function, the AUC for prediction of mortality was 0.897 (95% CI 0.778-1.0; P = 0.004) on day 2. CONCLUSIONS: The prognostic information of early post-procedural NT-proBNP concentrations is superior to pre-procedural values regarding all-cause mortality within 1 year. Post-procedural NT-proBNP must be interpreted in relation to the TAVR approach. NT-proBNP predicts mortality in TF-TAVR patients with AR and reduced left ventricular function.


Subject(s)
Aortic Valve Insufficiency/blood , Aortic Valve Insufficiency/mortality , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Transcatheter Aortic Valve Replacement/mortality , Ventricular Dysfunction, Left/blood , Ventricular Dysfunction, Left/mortality , Aged , Aged, 80 and over , Aortic Valve Insufficiency/surgery , Biomarkers/blood , Female , Follow-Up Studies , Humans , Male , Mortality/trends , Prospective Studies , Time Factors , Transcatheter Aortic Valve Replacement/trends , Ventricular Dysfunction, Left/surgery
2.
J Interv Card Electrophysiol ; 47(1): 75-82, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27033358

ABSTRACT

PURPOSE: Lesion formation is a critical determinant of technical and clinical success of pulmonary vein isolation. Different catheter designs aim to enhance tissue contact during ablation to enable optimized lesion formation. We analyzed procedural characteristics and predictors of clinical success in patients ablated with three different contemporary ablation catheters. METHODS: Two hundred sixty-eight sequentially included patients receiving pulmonary vein isolation (PVI) with conventional (n = 122), contact-force (n = 96) and flexible-tip (n = 60) catheters were followed for a median of 14.1 months with 7d-Holter-monitoring and TTE at 3, 6, 12, and 24 months. Baseline characteristics and follow-up times were homogeneous across all groups. RESULTS: Multivariable Cox proportional hazard regression for arrhythmia recurrence demonstrated a favorable hazard ratio for contact-force and flexible-tip catheters vs. conventional open irrigation catheters. Procedure time and fluoroscopy time were shorter for contact-force and flexible-tip catheters versus conventional catheters, but equal between. Linear lesions were applied in 58 % of contact-force and 66 % of flexible-tip cases, and CFAEs were targeted in 26 % of either. CONCLUSIONS: Our non-randomized prospectively collected data do not show a difference in observed procedure characteristics and in clinical outcome for flexible-tip versus contact-force catheter designs, while both display improved performance against conventional open irrigated-tip catheters. Linear lesions and CFAEs ablation were not associated with improved arrhythmia-free survival.


Subject(s)
Atrial Fibrillation/epidemiology , Atrial Fibrillation/surgery , Catheter Ablation/instrumentation , Catheter Ablation/statistics & numerical data , Monitoring, Intraoperative/instrumentation , Monitoring, Intraoperative/statistics & numerical data , Aged , Atrial Fibrillation/diagnosis , Catheter Ablation/methods , Disease-Free Survival , Elastic Modulus , Equipment Design , Equipment Failure Analysis , Female , Humans , Male , Middle Aged , Monitoring, Intraoperative/methods , Prevalence , Recurrence , Reproducibility of Results , Sensitivity and Specificity , Stress, Mechanical , Treatment Outcome
3.
Heart ; 92(11): 1639-44, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16740919

ABSTRACT

OBJECTIVE: To evaluate the prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with aortic stenosis being treated conservatively or undergoing aortic valve replacement (AVR). METHODS: 159 patients were followed up for a median of 902 days. 102 patients underwent AVR and 57 were treated conservatively. NT-proBNP at baseline was raised in association with the degree of severity and of functional status. RESULTS: During follow up 21 patients (13%) died of cardiac causes or required rehospitalisation for decompensated heart failure. NT-proBNP at baseline was higher in patients with an adverse outcome than in event-free survivors (median 623 (interquartile range 204-1854) pg/ml v 1054 (687-2960) pg/ml, p = 0.028). This difference was even more obvious in conservatively treated patients (331 (129-881) pg/ml v 1102 (796-2960) pg/ml, p = 0.002). Baseline NT-proBNP independently predicted an adverse outcome in the entire study group and in particular in conservatively treated patients (area under the curve (AUC) = 0.65, p = 0.028 and AUC = 0.82, p = 0.002, respectively) but not in patients undergoing AVR (AUC = 0.544). At a cut-off value of 640 pg/ml, baseline NT-proBNP was discriminative for an adverse outcome. CONCLUSION: NT-proBNP concentration is related to severity of aortic stenosis and provides independent prognostic information for an adverse outcome. However, this predictive value is limited to conservatively treated patients. Thus, the data suggest that assessing NT-proBNP may have incremental value for selecting the optimal timing of valve replacement.


Subject(s)
Aortic Valve Stenosis/blood , Natriuretic Peptide, Brain/metabolism , Peptide Fragments/metabolism , Aged , Aortic Valve Stenosis/mortality , Aortic Valve Stenosis/therapy , Biomarkers/blood , Disease-Free Survival , Echocardiography , Female , Heart Valve Prosthesis , Heart Valve Prosthesis Implantation , Humans , Male , Recurrence , Sensitivity and Specificity , Treatment Outcome
4.
Clin Res Cardiol ; 95(5): 270-80, 2006 May.
Article in English | MEDLINE | ID: mdl-16598393

ABSTRACT

BACKGROUND: Recently it has been found that BNP and NT-proBNP provide independent prognostic information in patients with acute coronary syndromes (ACS). However, little data are available on the time course of NT-proBNP levels in relation to onset of symptoms. METHODS AND RESULTS: We included 765 patients (236 females, aged 64 +/- 11 years) with an ACS (STEMI 42%, NSTEMI 41%, UAP 17%), who were referred for coronary angiography. NT-proBNP was assessed on admission and the next day. NT-proBNP values were related to the time duration from onset of symptoms until blood drawing with lowest values within 3 h and highest values 24-36 h after onset of symptoms (147 (64-436) pg/ml and 1099 (293-3795) pg/ml, respectively, p < 0.001). Highest values for NT-proBNP on admission were found in patients with NSTEMI compared to patients with STEMI and UAP (912 (310-2258) pg/ml) vs 262 (85-1282) pg/ml) vs 182 (74- 410) pg/ml; p < 0.001), but no difference was present between STEMI and NSTEMI the day after admission (1325 (532-2974) pg/ ml vs 1169 (555-3413) pg/ml; p = 0.676). In contrast NT-proBNP values remained unchanged in UAP (182 (74-410) pg/ml) vs 171 (53-474) pg/ml). CONCLUSION: The time interval from onset of symptoms to first blood collection is an important determinant for NT-proBNP values on admission in patients with an ACS and needs to be considered in clinical practice.


Subject(s)
Angina, Unstable/blood , Angina, Unstable/diagnosis , Myocardial Infarction/blood , Myocardial Infarction/diagnosis , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Biomarkers/blood , Female , Humans , Male , Middle Aged , Reproducibility of Results , Sensitivity and Specificity , Syndrome
5.
Z Kardiol ; 93(5): 381-7, 2004 May.
Article in German | MEDLINE | ID: mdl-15160273

ABSTRACT

Transthoracic electrical cardioversion using a monophasic waveform is the most common method converting persistent atrial fibrillation into sinus rhythm. Recently, cardioversion with a new biphasic waveform has shown promising results for treatment of atrial fibrillation. We undertook a randomized prospective trial comparing the efficacy and safety of the two waveforms for ambulatory cardioversion of atrial fibrillation. A total of 118 consecutive patients (mean age 62 years [SD 11]) presenting with persistent atrial fibrillation (mean duration 8 months [SD 11]) for ambulatory electrical cardioversion were randomized to receive either monophasic (n = 57) or biphasic shocks (n = 61). We used a standardized step-up protocol with increasing shock energies (100-360 joules) in either group. In all patients an anterior-posterior shock electrode position was used. If sinus rhythm was not achieved with the third (360 joules) shock, cardioversion was repeated with the opposite waveform. The two groups did not differ in demographic or disease-related data. The success rate was 100% for the biphasic and 73.7% for the monophasic waveform (p < 0.001). Biphasic patients required fewer shocks (1.5 versus 2.9) and a lower mean cumulative energy (203 versus 570 joules) (p < 0.001). Twelve out of 15 unsuccessfully treated monophasic patients were converted with biphasic shocks. The success rate for all 118 patients was 97.5%. No major acute complications were observed. For ambulatory transthoracic cardioversion of persistent atrial fibrillation biphasic shocks are of greater efficacy and require less energy than monophasic shocks. The procedure can be performed ambulatory and is safe regardless of shock waveform used.


Subject(s)
Ambulatory Care/methods , Ambulatory Care/statistics & numerical data , Atrial Fibrillation/epidemiology , Atrial Fibrillation/therapy , Electric Countershock/methods , Electric Countershock/statistics & numerical data , Female , Germany/epidemiology , Humans , Male , Middle Aged , Prospective Studies , Treatment Outcome
6.
Europace ; 5(4): 351-5, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14753629

ABSTRACT

AIM: The effect of applied therapy on quality of life (QoL) in patients with atrial fibrillation (AF) was investigated in recent studies. However, no information on clinical relevance of QoL assessing instruments in relation to post-ablation recurrence of AF is currently available. The aim of this study was to evaluate the clinical relevance of SF-36 and Arrhythmia Related Symptom Severity Check List (SSCL) to post-procedure AF recurrences in patients with paroxysmal AF undergoing pulmonary vein isolation (PVI). METHODS AND RESULTS: Sixty consecutive patients with AF were enroled in the study. The QoL was measured using SF-36 scale and SSCL. The questionnaires were administered at baseline then 3, 6, 9 and 12 months after the procedure. In order to define statistical power in relation to AF recurrence the scores were dichotomized. Positive and negative predictive accuracy (PPA, NPA) and test efficiency (sum of PPA and NPA) were calculated. Twenty-one out of 60 patients experienced a total of 66 recurrences of AF during follow-up. The parameters of SF-36 provided maximum test efficiency of 1.36, whereas the test efficiency of SSCL was 1.79. CONCLUSION: We conclude that SSCL is more specific instrument for a measurement of PVI success or failure.


Subject(s)
Atrial Fibrillation/diagnosis , Atrial Fibrillation/surgery , Health Surveys , Severity of Illness Index , Catheter Ablation , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pilot Projects , Predictive Value of Tests , Pulmonary Veins/surgery , Quality of Life , Recurrence , Surveys and Questionnaires , Time Factors
7.
Ann Ist Super Sanita ; 37(3): 409-18, 2001.
Article in English | MEDLINE | ID: mdl-11889958

ABSTRACT

Symbolic dynamics as a non linear method and computation of the normalized algorithmic complexity (C alpha) was applied to basket-catheter mapping of atrial fibrillation (AF) in the right human atrium. The resulting different degrees of organisation of AF have been compared to conventional classification of Wells. Short time temporal and spatial distribution of the C alpha during AF and effects of propafenone on this distribution have been investigated in 30 patients. C alpha was calculated for a moving window. Generated C alpha was analyzed within 10 minutes before and after administration of propafenone. The inter-regional C alpha distribution was statistically analyzed. Inter-regional C alpha differences were found in all patients (p < 0.001). The right atrium could be divided in high- and low complexity areas according to individual patterns. A significant C alpha increase in cranio-caudal direction was confirmed inter-individually (p < 0.01). The administration of propafenone enlarged the areas of low complexity.


Subject(s)
Algorithms , Atrial Fibrillation/physiopathology , Cardiac Catheterization , Anti-Arrhythmia Agents/therapeutic use , Atrial Fibrillation/drug therapy , Cardiac Catheterization/instrumentation , Female , Humans , Male , Middle Aged , Propafenone/therapeutic use
8.
Med Klin (Munich) ; 96(12): 708-12, 2001 Dec 15.
Article in German | MEDLINE | ID: mdl-11785371

ABSTRACT

AIM: The aim of the study was to analyze the medical history of patients with AV-nodal reentry tachycardia (AVNRT). PATIENTS AND METHODS: Between 1990 and 1999 radiofrequency catheter ablation was performed in 1,024 patients suffering from AVNRT. Data of the previous history were comprehended by questionnaire. RESULTS: 748 (73%) patients replied to the questionnaire. The interval between the first appearance of the symptoms and the catheter ablation was 4.1 +/- 1.5 years. The mean age of the patients was 55.4 years (female) and 58.7 years (male). Merely 6% of all patients had a structural heart disease. The mean duration of case history was 16.8 years. In comparison to the male patients, the assignment for female patients to catheter ablation was after a significant 7 years longer lasting anamnesis. The distribution of age showed that the first tachycardia appeared in 16% of the female patients older than 50 years of age and only in 17% younger than 20 years of age; the corresponding percentages for men were 31% and 18%. With reference to the duration of the longest tachycardia episodes and arrhythmia-related presyncopes and syncopes, women showed a more defined symptomatic. On 20% of the patients a radiofrequency catheter ablation ensued without previous antiarrhythmic treatment; 80% of the patients were treated with 2.8 different antiarrhythmic medications. Medical consultations regarding AVNRT were named as follows (mean/range): family doctor 6.1/1-250, emergency physicians 1.1/0-15, hospital 1.0/0-20. The indication for catheter ablation was set by the family doctor in 13% and by the cardiologist in 77%. Patients got their information about catheter ablation in 2.9% from acquainted persons or news services. CONCLUSION: There is no "typical" anamnesis of AVNRT patients. There is an amazingly high rate of patients with an AVNRT begin in elder stage of age and the fact of therapy delay of 7 years in behalf of women.


Subject(s)
Catheter Ablation , Tachycardia, Atrioventricular Nodal Reentry/surgery , Adult , Aged , Electrocardiography , Female , Follow-Up Studies , Germany , Humans , Male , Middle Aged , Patient Care Team , Tachycardia, Atrioventricular Nodal Reentry/diagnosis , Tachycardia, Atrioventricular Nodal Reentry/physiopathology , Treatment Outcome
9.
J Interv Card Electrophysiol ; 4(2): 383-94, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10936004

ABSTRACT

UNLABELLED: A recently developed algorithm that is based on symbolic dynamics and computation of the normalized algorithmic complexity (C(alpha)) was applied to basket-catheter mapping of the atrial fibrillation (AF). The aim of our study was to analyze the spatial distribution of the C(alpha) during AF and effects of propafenone on this distribution. During right atrial mapping in 25 patients with AF 31 intra-atrial and 1 surface bipolar channels were acquired. The anatomical location of the intra-atrial electrodes was defined fluoroscopically. C(alpha) was calculated for a moving window (size: 2000 points; step 500 points). Generated C(alpha) was analyzed within 10 minutes before and after administration of propafenone. The inter-regional C(alpha) distribution was analyzed using the Friedman-test (intra-individually) and Kruskall-Wallis-H-test (inter- individually). A value of p=0.05 was set for an error probability. Inter-regional C(alpha) differences were found in all patients (p<0.001). The right atrium could be divided in high- and low complexity areas according to individual patterns. A significant C(alpha) increase in cranio-caudal direction (with the exception of septum) was confirmed inter-individually (p<0.01). The administration of propafenone enlarged the areas of low complexity. CONCLUSIONS: This new method utilizing the combination of symbolic dynamics and adaptive power estimation can provide complex evaluation of the dynamics of AF in man. High-density mapping will be required for further evaluation of results.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Atrial Fibrillation/physiopathology , Electrophysiologic Techniques, Cardiac , Propafenone/pharmacology , Algorithms , Body Surface Potential Mapping , Female , Humans , Male , Middle Aged
10.
Pacing Clin Electrophysiol ; 23(11 Pt 2): 1852-5, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11139941

ABSTRACT

The aim of this study was to compare the efficacy of pulsed versus continuous RF energy delivery via multipolar ablation catheters. In vitro tests were performed in endomyocardial preparations of fresh bovine hearts in a both of physiological saline solution (37 degrees C) at constant flow conditions (1.5 L/min). The catheters were applied to the endocardium at a constant pressure. Energy was delivered pulsed (to 4 electrodes simultaneously, 5-ms duty cycle) or continuously (to each electrode separately). In vivo experiments were performed under fluoroscopy in eight anesthetized pigs, guided by endocardial electrograms to place the catheters in 22 different intraatrial positions. Lesion volume was calculated from measurements of the lesion diameter with a microcaliper. The homogeneity of the lesions was classified from 1 (highest) to 4 (least). More homogeneous linear lesions were produced in significantly less time with pulsed than with continuous energy delivery. There were no differences in electrode temperature or impedance values in vitro and in vivo. The results in the in vitro experiments were reproducible in the intact animal experiments. Significantly larger and more homogeneous linear lesions were created more rapidly with pulsed than with continuous energy delivery.


Subject(s)
Catheter Ablation/methods , Catheterization/instrumentation , Heart Atria/surgery , Heart Ventricles/surgery , Animals , Catheter Ablation/adverse effects , Cattle , Heart Atria/pathology , Heart Ventricles/pathology , In Vitro Techniques , Pericardial Effusion/etiology , Reproducibility of Results , Swine
11.
J Interv Card Electrophysiol ; 4(4): 655-61, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11141213

ABSTRACT

BACKGROUND: For invasive treatment of atrial fibrillation, linear lesions induced with multipolar ablation catheters (MAC) are needed to prevent recurrence. The aim of the study was to compare the efficacy of pulsed versus continuous radiofrequency (RF)-energy delivery using MAC. METHODS: In vitro tests were performed using endomyocardial preparations of fresh pig hearts in a 10-liter-bath of physiologic saline solution (37 degrees C) at constant flow conditions (1.5 l/min). The MAC were placed with a constant pressure of 20 ponds onto the endocardium. The energy (generator: Osypka HAT 200 S) was delivered either pulsed (4 electrodes simultaneously, 5ms duty-cycle) or continuously (each electrode separately). In vivo experiments were performed in 6 anesthetized pigs using fluoroscopic positioning of MAC at 40 different intracardial positions and with similar conditions as in vitro experiments. Lesion volume (LV) was calculated after measuring lesion diameter with a microcaliper. The homogeneity of the lesions (LH) was classified from 1-4; with 1 as highest homogeneity. RESULTS: Pulsed energy delivery produced more homogeneous linear lesions in significantly less time. There was no difference in electrode temperature values (50.2 +/- 0.8 and 51.3 +/- 1.4 degrees C) in vitro and in vivo. In the in vivo experiments, lesion depth and calculated lesion volume were less in both modes of energy delivery but pulsed energy delivery was superior regarding lesion depth and homogeneity. CONCLUSION: With pulsed energy delivery it is possible to create linear lesions of significantly greater homogeneity. Moreover, larger lesions are induced in less time by pulsed energy delivery in vitro and in vivo.


Subject(s)
Catheter Ablation/methods , Linear Energy Transfer , Myocardium/pathology , Animals , Organ Culture Techniques , Radio Waves , Sensitivity and Specificity , Swine
12.
Am J Cardiol ; 79(2): 205-6, 1997 Jan 15.
Article in English | MEDLINE | ID: mdl-9193027

ABSTRACT

In implantable cardioverter-defibrillator therapy with endocardial lead systems, certain clinical variables are associated with defibrillation energy requirements. Because of the weak correlation coefficients, these variables cannot predict defibrillation thresholds in individual patients.


Subject(s)
Electric Countershock , Age Factors , Amiodarone/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Cardiac Surgical Procedures , Coronary Disease/physiopathology , Defibrillators, Implantable , Electric Countershock/methods , Electrophysiology , Equipment Design , Female , Forecasting , Humans , Male , Middle Aged , Multivariate Analysis , Myocardial Ischemia/physiopathology , Regression Analysis , Sex Factors , Sotalol/therapeutic use , Stroke Volume , Tachycardia, Ventricular/physiopathology , Ventricular Fibrillation/physiopathology , Ventricular Fibrillation/therapy , Ventricular Function, Left
SELECTION OF CITATIONS
SEARCH DETAIL
...